Scripps Research Institute

Awards to the Institution

Program	Investigator	Award Title	Award Value
Tools and Technologies I	Jeanne Loring	The Stem Cell Matrix: a map of the molecular pathways that define pluripotent cells	$1,133,552
Early Translational III	Peter Schultz	Targeting Stem Cells to Enhance Remyelination in the Treatment of Multiple Sclerosis	$2,559,333
New Faculty I	Kristin Baldwin	Generating pluripotent cell lines from neurons.	$2,786,560
Transplantation Immunology	Nicholas Gascoigne	Role of Innate Immunity in hematopoeitic stem cell-mediated allograft tolerance	$1,705,554
Creativity Awards	James Williamson	Stem Cell Summer Academy: Creating the Next Generation of Scientists	$205,122
Quest - Discovery Stage Research Projects	Stuart Lipton	Drug Development for Autism Spectrum Disorder Using Human Patient iPSCs	$1,827,576
Early Translational II	Peter Schultz	Cartilage Regeneration by the Chondrogenic Small Molecule PRO1 during Osteoarthritis	$6,047,249
Transplantation Immunology	Jeanne Loring	Thymus based tolerance to stem cell therapies	$1,108,921
New Cell Lines	Sheng Ding	Derivation of New ICM-stage hESCs	$936,973
Discovery Research Projects	Stuart Lipton	Repurposing Aminoadamantane Nitrate Compounds to Inhibit SARS-CoV-2 Viral Activity and to Protect the Brain from Viral-Related Damage	$150,000
SEED Grant	Peter Schultz	A Chemical Approach to Stem Cell Biology	$748,944
Shared Labs	Sheng Ding	TSRI Center for hESC Research	$1,440,164
Research Training Grant	Peter Schultz	Training Scholars in Regenerative Medicine and Stem Cell Research	$4,931,353
Early Translational I	Jeanne Loring	Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation	$5,830,771
Basic Biology III	Joel Gottesfeld	Triplet Repeat Instability in Human iPSCs	$1,705,494
New Faculty I	Sheng Ding	Reprogramming of human somatic cells back to pluripotent embryonic stem cells	$1,393,876
Quest - Discovery Stage Research Projects	Luke Lairson	Improving the efficacy and tolerability of clinically validated remyelination-inducing molecules using developable combinations of approved drugs	$1,554,126
Early Translational I	Martin Friedlander	Autologous Retinal Pigmented Epithelial Cells Derived from Induced Pluripotent Stem Cells for the Treatment of Atrophic Age Related Macular Degeneration	$5,806,321
Basic Biology III	Kristin Baldwin	Identifying sources of mutation in human induced pluripotent stem cells by whole genome sequencing	$1,705,500
Tools and Technologies III	Jeanne Loring	User-friendly predictive molecular diagnostic assays for quality control of stem cell derivatives for transplantation and drug discovery	$1,728,390
Quest - Discovery Stage Research Projects	Michael Bollong	Therapeutics to overcome the differentiation roadblock in Myelodysplastic Syndrome (MDS)	$1,244,160
Shared Labs	Jeanne Loring	TSRI Center for hESC Research	$3,725,070
Research Training II	Ulrich Mueller	Training Stem Cell Researchers at the Chemistry-Biology Interface	$3,697,326
Quest - Discovery Stage Research Projects	Jeanne Loring	Autologous cell therapy for Parkinson’s disease using iPSC-derived DA neurons	$2,299,786
Quest - Discovery Stage Research Projects	Stuart Lipton	Drug Development of Inhibitors of Inflammation Using Human iPSC-Derived Microglia (hiMG)	$1,658,123
Tools and Technologies I	Carlos Barbas	Development of a novel technology for precise, efficient, and safe genetic modification of stem cells	$1,138,548
Training Grant I-2	Peter Schultz	Training Grant I	$1,021,395
Conference	Jeanne Loring	World Stem Cell Summit	$30,000
New Faculty I	Kristin Baldwin	Generating pluripotent cell lines from neurons.	$2,786,560
			Total: $62,906,747.00